MedTrace Logo

Intranasal Dexmedetomidine vs Midazolam-ketamine Combination for Premedication of Pediatric Patients

NCT02072083 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2015-04-14

No results posted yet for this study

Summary

The aim of this study is using intranasal dexmedetomidine versus intranasal midazolam-ketamine combination for premedication and preventing the oculocardiac reflex of pediatric patients undergoing strabismus surgery.

Conditions

  • Premedication
  • Oculocardiac Reflex

Interventions

DRUG

Dexmedetomidine

via intranasal route 1 mcg/kg

DRUG

Ketamine

via intranasal route 7,5 mg/kg ketamine and 0,1 mg/kg midazolam

Sponsors & Collaborators

  • TC Erciyes University

    lead OTHER

Principal Investigators

  • Müge Yüce Yıldırım, resident · erciyes univercity

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
11 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02072083 on ClinicalTrials.gov